Showing results (41-50 of 130) with videos related to

Sort By:
Pageof 13
Annals of Hematology|March 12, 2021
Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantationArjun Datt Law, Sita Bhella, Ivan Pasic, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 7, 2016
Myeloablative versus Reduced-Intensity Conditioning in Patients with Myeloid Malignancies: A Propensity Score-Matched AnalysisHassan Sibai, Umberto Falcone, Uday Deotare, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 7, 2019
Combination of the Centre for International Blood and Marrow Transplant Registry Risk Score and the Global Severity Score Enhances Prognostic Risk Stratification in Patients Receiving Frontline Therapy for Chronic Graft-versus-Host DiseaseRoman M Shapiro, Elizabeth Shin, Arjun Datt Law, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2014
Incidence, risk factors, and long-term outcomes of sclerotic graft-versus-host disease after allogeneic hematopoietic cell transplantationJieun Uhm, Nada Hamad, Elizabeth M Shin, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2014
Modified EBMT Pretransplant Risk Score Can Identify Favorable-risk Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for AML, Not Identified by the HCT-CI ScoreFotios V Michelis, Hans A Messner, Jieun Uhm, et al.
European Journal of Haematology|September 13, 2019
Reduced-intensity conditioning allogeneic transplant with dual T-cell depletion in myelofibrosisMaria Queralt Salas, Wilson Lam, Arjun Datt Law, et al.
European Journal of Haematology|August 17, 2019
Impact of central nervous system involvement in AML on outcomes after allotransplant and utility of pretransplant cerebrospinal fluid assessmentShruti Prem, Eshetu G Atenafu, Jose Avena, et al.
European Journal of Haematology|March 30, 2019
Low rates of acute and chronic GVHD with ATG and PTCy in matched and mismatched unrelated donor peripheral blood stem cell transplantsShruti Prem, Eshetu G Atenafu, Zeyad Al-Shaibani, et al.
Transplantation and Cellular Therapy|June 13, 2025
Association of Cyclosporine Exposure Post-Allogeneic Hematopoietic Cell Transplant with Graft Failure and Relapse Risk in Hematological MalignanciesAhmed Alnughmush, Mats Remberger, Vathany Kulasingam, et al.
European Journal of Haematology|January 31, 2022
Allogeneic hematopoietic stem cell transplantation in patients with therapy-related hematologic malignancies developing after multiple myelomaRam Vasudevan Nampoothiri, Ivan Pasic, Arjun Datt Law, et al.
Pageof 13